{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:49:52Z","timestamp":1790743792518,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":1614,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1124\/jpet.120.266122","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T23:44:32Z","timestamp":1591227872000},"page":"252-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["MK-8719, a Novel and Selective O-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of Tauopathy"],"prefix":"10.1016","volume":"374","author":[{"given":"Xiaohai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Terracina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok-Lam Karen","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry X.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kinsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry P.","family":"Melchor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Rubins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hostetler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Sur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel B.","family":"Schachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Fred","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold G.","family":"Selnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Vocadlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest J.","family":"McEachern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Uslaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.120.266122_bib1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat Rev Neurosci"},{"issue":"Suppl 2","key":"10.1124\/jpet.120.266122_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-2011-110161","article-title":"Tau transgenic mice as models for cerebrospinal fluid tau biomarkers","volume":"24","author":"Barten","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1124\/jpet.120.266122_bib3","doi-asserted-by":"crossref","first-page":"e84442","DOI":"10.1371\/journal.pone.0084442","article-title":"Increasing brain protein O-GlcNAc-ylation mitigates breathing defects and mortality of Tau.P301L mice","volume":"8","author":"Borghgraef","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/jpet.120.266122_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.120.266122_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0014-5793(99)00222-7","article-title":"Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation","volume":"446","author":"Dayanandan","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.120.266122_bib6","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00259-003-1194-1","article-title":"Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer\u2019s disease: a PET follow-up study","volume":"30","author":"Drzezga","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1124\/jpet.120.266122_bib7","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.52.8.1687","article-title":"Correlation between rates of brain atrophy and cognitive decline in AD","volume":"52","author":"Fox","year":"1999","journal-title":"Neurology"},{"key":"10.1124\/jpet.120.266122_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1124\/jpet.120.266122_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.devcel.2014.10.020","article-title":"O-GlcNAcylation prevents aggregation of the Polycomb group repressor polyhomeotic","volume":"31","author":"Gambetta","year":"2014","journal-title":"Dev Cell"},{"key":"10.1124\/jpet.120.266122_bib10","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1021\/bi000201f","article-title":"In vitro polymerization of tau protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants","volume":"39","author":"Gamblin","year":"2000","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.120.266122_bib11","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jalz.2016.02.011","article-title":"O-GlcNAcylation: a regulator of tau pathology and neurodegeneration","volume":"12","author":"Gong","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1124\/jpet.120.266122_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuropharm.2013.11.025","article-title":"Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy","volume":"79","author":"Graham","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.120.266122_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1124\/jpet.120.266122_bib14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nature05815","article-title":"Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins","volume":"446","author":"Hart","year":"2007","journal-title":"Nature"},{"key":"10.1124\/jpet.120.266122_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13024-017-0181-0","article-title":"Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice","volume":"12","author":"Hastings","year":"2017","journal-title":"Mol Neurodegener"},{"key":"10.1124\/jpet.120.266122_bib16","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0531-5565(00)00156-X","article-title":"Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update","volume":"35","author":"Hoyer","year":"2000","journal-title":"Exp Gerontol"},{"key":"10.1124\/jpet.120.266122_bib17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","article-title":"Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17","volume":"393","author":"Hutton","year":"1998","journal-title":"Nature"},{"key":"10.1124\/jpet.120.266122_bib18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1212\/01.WNL.0000110315.26026.EF","article-title":"Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD","volume":"62","author":"Jack","year":"2004","journal-title":"Neurology"},{"key":"10.1124\/jpet.120.266122_bib19","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.1124\/jpet.120.266122_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbagen.2009.08.008","article-title":"Dysregulation of the nutrient\/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer\u2019s disease","volume":"1800","author":"Lefebvre","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.120.266122_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0304-4165(02)00477-4","article-title":"Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization","volume":"1619","author":"Lefebvre","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.120.266122_bib22","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1073\/pnas.1808845116","article-title":"\u03b1-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson\u2019s disease","volume":"116","author":"Levine","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.120.266122_bib23","unstructured":"Li WP, Salinas C, Riffel K, Miller P, Zeng ZZ, Lohith T, Selnick HG, Purcell M, Holahan M, Meng XJ (2016) The discovery and characterization of [18F]MK-8553, a novel PET tracer for imaging O-GlcNAcase (OGA), in International Symposium on Function NeuroReceptor Mapping of the Living Brain (NRM2016); Boston, MA."},{"key":"10.1124\/jpet.120.266122_bib24","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1073\/pnas.0400348101","article-title":"O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer\u2019s disease","volume":"101","author":"Liu","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.120.266122_bib25","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/brain\/awp099","article-title":"Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer\u2019s disease","volume":"132","author":"Liu","year":"2009","journal-title":"Brain"},{"key":"10.1124\/jpet.120.266122_bib26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nchem.2361","article-title":"O-GlcNAc modification blocks the aggregation and toxicity of the protein \u03b1-synuclein associated with Parkinson\u2019s disease","volume":"7","author":"Marotta","year":"2015","journal-title":"Nat Chem"},{"key":"10.1124\/jpet.120.266122_bib27","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neuint.2010.12.023","article-title":"Post-translational modifications of tau protein: implications for Alzheimer\u2019s disease","volume":"58","author":"Martin","year":"2011","journal-title":"Neurochem Int"},{"key":"10.1124\/jpet.120.266122_bib28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","article-title":"Brain glucose metabolism in the early and specific diagnosis of Alzheimer\u2019s disease. FDG-PET studies in MCI and AD","volume":"32","author":"Mosconi","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1124\/jpet.120.266122_bib29","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/MCB.24.4.1680-1690.2004","article-title":"Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability","volume":"24","author":"O\u2019Donnell","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.120.266122_bib30","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.bbadis.2018.10.037","article-title":"Diminished O-GlcNAcylation in Alzheimer\u2019s disease is strongly correlated with mitochondrial anomalies","volume":"1865","author":"Pinho","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1124\/jpet.120.266122_bib31","doi-asserted-by":"crossref","first-page":"10637","DOI":"10.1523\/JNEUROSCI.3279-05.2005","article-title":"Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)","volume":"25","author":"Ramsden","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.120.266122_bib32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"Santacruz","year":"2005","journal-title":"Science"},{"key":"10.1124\/jpet.120.266122_bib33","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.neuropsychologia.2008.02.015","article-title":"Neuropsychological correlates of whole brain atrophy in Alzheimer\u2019s disease","volume":"46","author":"Schott","year":"2008","journal-title":"Neuropsychologia"},{"key":"10.1124\/jpet.120.266122_bib34","doi-asserted-by":"crossref","first-page":"10062","DOI":"10.1021\/acs.jmedchem.9b01090","article-title":"Discovery of MK-8719, a potent O-GlcNAcase inhibitor as a potential treatment for tauopathies","volume":"62","author":"Selnick","year":"2019","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.120.266122_bib35","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.neurobiolaging.2008.06.016","article-title":"Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study","volume":"31","author":"Sluimer","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.1124\/jpet.120.266122_bib36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13024-015-0011-1","article-title":"Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology","volume":"10","author":"Song","year":"2015","journal-title":"Mol Neurodegener"},{"issue":"Suppl 1","key":"10.1124\/jpet.120.266122_bib37","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.neuroimage.2004.07.071","article-title":"Mapping cortical change in Alzheimer\u2019s disease, brain development, and schizophrenia","volume":"23","author":"Thompson","year":"2004","journal-title":"Neuroimage"},{"key":"10.1124\/jpet.120.266122_bib38","doi-asserted-by":"crossref","first-page":"e0195486","DOI":"10.1371\/journal.pone.0195486","article-title":"Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"},{"key":"10.1124\/jpet.120.266122_bib39","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1016\/j.neuroimage.2010.10.067","article-title":"Volumetric MRI and MRS provide sensitive measures of Alzheimer\u2019s disease neuropathology in inducible Tau transgenic mice (rTg4510)","volume":"54","author":"Yang","year":"2011","journal-title":"Neuroimage"},{"key":"10.1124\/jpet.120.266122_bib40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nrm.2017.22","article-title":"Protein O-GlcNAcylation: emerging mechanisms and functions","volume":"18","author":"Yang","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/jpet.120.266122_bib41","doi-asserted-by":"crossref","first-page":"e35277","DOI":"10.1371\/journal.pone.0035277","article-title":"Differential effects of an O-GlcNAcase inhibitor on tau phosphorylation","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/jpet.120.266122_bib42","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jmb.2014.01.004","article-title":"O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers","volume":"426","author":"Yuzwa","year":"2014","journal-title":"J Mol Biol"},{"key":"10.1124\/jpet.120.266122_bib43","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nchembio.96","article-title":"A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo","volume":"4","author":"Yuzwa","year":"2008","journal-title":"Nat Chem Biol"},{"key":"10.1124\/jpet.120.266122_bib44","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nchembio.797","article-title":"Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation","volume":"8","author":"Yuzwa","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1124\/jpet.120.266122_bib45","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1021\/acschemneuro.8b00015","article-title":"Pharmacological inhibition of O-GlcNAcase enhances autophagy in brain through an mTOR-independent pathway","volume":"9","author":"Zhu","year":"2018","journal-title":"ACS Chem Neurosci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524258158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524258158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.120.266122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T17:19:07Z","timestamp":1740763147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524258158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0022356524258158"],"URL":"https:\/\/doi.org\/10.1124\/jpet.120.266122","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MK-8719, a Novel and Selective O-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of Tauopathy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.120.266122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The Author(s)","name":"copyright","label":"Copyright"}]}}